Literature DB >> 22826305

LupusQoL-FR is valid to assess quality of life in patients with systemic lupus erythematosus.

Hervé Devilliers1, Zahir Amoura, Jean-Francois Besancenot, Bernard Bonnotte, Jean-Louis Pasquali, Denis Wahl, Francois Maurier, Pierre Kaminsky, Jean-Loup Pennaforte, Nadine Magy-Bertrand, Laurent Arnaud, Christine Binquet, Francis Guillemin.   

Abstract

OBJECTIVE: To cross-culturally adapt the LupusQoL into French, to test its measurement properties and to further investigate its domain structure.
METHODS: The cultural adaptation process according to guidelines and pre-testing resulted in the LupusQoL-FR. SLE patients completed the LupusQoL-FR at baseline, 15 days, 3 months and 6 months. Validity was studied through content and construct validity (factorial and Rasch analysis for structural validity, Spearman's correlation and Mann-Whitney tests for external validity). Cronbach's α and intra-class correlation coefficients were computed for reliability. The standardized response mean was computed to evaluate responsiveness.
RESULTS: In all, 182 patients, age 39.6 (10.6) years, mostly outpatients [mean SELENA-SLEDAI 2.6 (3.5)] were recruited. Factor analysis with eight imposed factors was very close to the original LupusQoL. A screeplot with parallel analysis showed that LupusQoL domains could be aggregated in two physical and mental scales. Both eight- and two-factor structures showed a good Rasch fit, internal consistency (Cronbach's α: 0.85-0.95), and test-retest reliability (intra-class correlation coefficient 0.79-0.95). External convergent (correlation with SF-36, r=0.59-0.78) and divergent validity (according to SELENA-SLEDAI) were also satisfactory.
CONCLUSION: The LupusQoL-FR is valid to assess quality of life in SLE patients. A two-factor structure of physical and mental aggregated scales is a valid alternative to the original eight-domain structure.

Entities:  

Mesh:

Year:  2012        PMID: 22826305     DOI: 10.1093/rheumatology/kes165

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  10 in total

Review 1.  Top 10 recent developments in health-related quality of life in patients with systemic lupus erythematosus.

Authors:  Anisha B Dua; Zahi Touma; Sergio Toloza; Meenakshi Jolly
Journal:  Curr Rheumatol Rep       Date:  2013-12       Impact factor: 4.592

2.  Components of quality of life in a sample of patients with lupus: a confirmatory factor analysis and Rasch modeling of the LupusQoL.

Authors:  Ana-Belén Meseguer-Henarejos; Juan-José Gascón-Cánovas; José-Antonio López-Pina
Journal:  Clin Rheumatol       Date:  2017-05-02       Impact factor: 2.980

Review 3.  The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus.

Authors:  Ozan Ünlü; Stephane Zuily; Doruk Erkan
Journal:  Eur J Rheumatol       Date:  2015-12-29

Review 4.  Patient-Reported Outcomes in Systemic Lupus Erythematosus.

Authors:  Mary Mahieu; Susan Yount; Rosalind Ramsey-Goldman
Journal:  Rheum Dis Clin North Am       Date:  2016-03-17       Impact factor: 2.670

5.  Linguistic Validation of the LupusQoL for the Assessment of Quality of Life in Iranian Patients with Systemic Lupus Erythematosus.

Authors:  Naeimehossadat Hosseini; Zahra Sayed Bonakdar; Ali Gholamrezaei; Leila Mirbagher
Journal:  Int J Rheumatol       Date:  2014-09-09

6.  Factors Associated with Health-Related Quality of Life in Mexican Lupus Patients Using the LupusQol.

Authors:  I Etchegaray-Morales; S Méndez-Martínez; C Jiménez-Hernández; C Mendoza-Pinto; N E Alonso-García; A Montiel-Jarquín; A López-Colombo; A García-Villaseñor; M H Cardiel; M García-Carrasco
Journal:  PLoS One       Date:  2017-01-23       Impact factor: 3.240

7.  Validation of the Malayalam Version of Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale in Cancer Patients in the Regional Cancer Centre, Thiruvananthapuram, Kerala, India.

Authors:  Shoukkathali Anzar; Cherian Koshy; Kurian Mathew Abraham
Journal:  Indian J Palliat Care       Date:  2017 Jul-Sep

8.  Health and quality of life outcomes.

Authors:  Meenakshi Jolly; Winston Sequeira; Joel A Block
Journal:  Health Qual Life Outcomes       Date:  2014-12-12       Impact factor: 3.186

9.  Patient-reported outcome measures for use in clinical trials of SLE: a review.

Authors:  Zara Izadi; Julie Gandrup; Patricia P Katz; Jinoos Yazdany
Journal:  Lupus Sci Med       Date:  2018-08-21

10.  A Comparison of the Correlation of Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) and Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) with Health-Related Quality of Life.

Authors:  Ning-Sheng Lai; Ming-Chi Lu; Hsiu-Hua Chang; Hui-Chin Lo; Chia-Wen Hsu; Kuang-Yung Huang; Chien-Hsueh Tung; Bao-Bao Hsu; Cheng-Han Wu; Malcolm Koo
Journal:  J Clin Med       Date:  2021-05-15       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.